Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-007804
Filing Date
2014-02-05
Accepted
2014-02-05 20:51:28
Documents
2
Period of Report
2014-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10312
2 EX-24 DOCUMENT attachment1.htm EX-24 4282
  Complete submission text file 0001209191-14-007804.txt   17517
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609
Business Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609 919-459-8620
NovaQuest Pharma Opportunities Fund III, L.P. (Reporting) CIK: 0001506260 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 14577794

Mailing Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609
Business Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609 (919) 459-8620
NQ HCIF GP, Ltd. (Reporting) CIK: 0001598203 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 14577792

Mailing Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609
Business Address 4208 SIX FORKS ROAD SUITE 920 RALEIGH NC 27609 (919) 459-8620
NQ HCIF General Partner, L.P. (Reporting) CIK: 0001598327 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36297 | Film No.: 14577793